Co-inventor Dr. Torben Mogensen joins OncoZenge advisory board ahead of phase III
11 december, 10:45
11 december, 10:45
As OncoZenge prepares for its European phase III pain management programme for BupiZenge – with first patient targeted for Q2026 XNUMX – the company is advancing key clinical, manufacturing and operational workstreams. OncoZenge recently appointed co-inventor Dr. Torben Mogensen to its advisory board, and BioStock reached out to him for a comment.
Read the full interview at biostock.se:
The inventor behind BupiZenge takes a seat on OncoZenge's advisory board ahead of phase III
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
11 december, 10:45
As OncoZenge prepares for its European phase III pain management programme for BupiZenge – with first patient targeted for Q2026 XNUMX – the company is advancing key clinical, manufacturing and operational workstreams. OncoZenge recently appointed co-inventor Dr. Torben Mogensen to its advisory board, and BioStock reached out to him for a comment.
Read the full interview at biostock.se:
The inventor behind BupiZenge takes a seat on OncoZenge's advisory board ahead of phase III
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Fonder
Utredningen mot Intellego
Aktierekar
Försvarsaktier


Fonder
Utredningen mot Intellego
Aktierekar
Försvarsaktier


1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 863,86